Acelyrin unveils phase 3 program design for lonigutamab in thyroid eye disease
The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.
Related Articles
2025: A Year for Achieving Physician Payment Reform and Promoting Innovation
Michael X. Repka, MD, MBA, 2025 Academy President, on what Academy members should expect in the new year.
FDA clears Epithelial Thickness Module for Anterion imaging platform
The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press release.“Anterion technology stands out in the…
Episode 453
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma
The long-term analysis show clinically and statistically significant reductions in intraocular pressure through up to 36 months postoperatively.
Rotational stability of plate-haptic toric intraocular… : Journal of Cataract & Refractive Surgery
randomized, paired-eye study. Methods: Patients with bilateral cataracts and coexisting regular corneal astigmatism were enrolled. The 2 eyes of each patient were randomly assigned to…
Efficacy and Safety of Prophylactic Agents in Prevention of Retinopathy of Prematurity: A Systematic Review and Meta-analysis of Randomised Controlled rials
Objective Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness in preterm infants with low birth weight. The efficacy and safety of…
Oculis releases positive topline results from phase 2 ACUITY trial evaluating OCS-05 in acute optic neuritis
The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to abnormal in any electrocardiogram (ECG).
Free Resources in Support of National Glaucoma Awareness Month – Prevent Blindness
Prevent Blindness joins efforts in January for National Glaucoma Awareness Month to provide patients, care partners, and professionals with free educational
Hard Conversations
Four ophthalmologists discuss challenges, offer guidance to colleagues whose patients are losing their vision.